))
Discussion : Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use
Manage episode 408807183 series 2806350
Innhold levert av Dr. Heather Quaile, DNP,WHNP-BC & Jackie Piasta MSN, WHNP-BC, Dr. Heather Quaile, DNP, and Jackie Piasta MSN. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr. Heather Quaile, DNP,WHNP-BC & Jackie Piasta MSN, WHNP-BC, Dr. Heather Quaile, DNP, and Jackie Piasta MSN eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
We took some time to discuss this recent article which is very timely and it compared weight loss response and changes in cardiometabolic risk markers in postmenopausal women using semaglutide with and without menopause hormone therapy (HT) use. In postmenopausal women with overweight or obesity treated with semaglutide, HT use was associated with an improved weight loss response. It was a small study size of 60 women but nonetheless good data. Larger studies should be conducted to confirm these results.
Article: https://pubmed.ncbi.nlm.nih.gov/38446869/
To Follow US check out:
Heather- www.theshowcenter.com
Jackie- https://www.mymonarchhealthco.com
The podcast- @justaskhive
Heather- @drquailenp
Jackie- @jackiep_gynnp
Tara @thesexualhealthpharmacist
The course is live and available at:
the-hive8.teachable.com
54 episoder
Del
